Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomaras

Showing results (301-310 of 525) with videos related to

Pageof 53
Sort By:
The Journal of Infectious Diseases|February 2, 2011
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Alicia Sato, et al.
Plos Pathogens|February 25, 2011
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infectionGuido Ferrari, Bette Korber, Nilu Goonetilleke, et al.
Plos One|May 10, 2016
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre StudyCatherine A Cosgrove, Charles J Lacey, Alethea V Cope, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Plos One|December 6, 2011
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41S Moses Dennison, Laura L Sutherland, Frederick H Jaeger, et al.
Communications Biology|October 2, 2018
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cellsMaria Blasi, Donatella Negri, Celia LaBranche, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
Pageof 53

Showing results (301-310 of 525) with videos related to

Sort By:
Pageof 53
The Journal of Infectious Diseases|February 2, 2011
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particlesPaul A Goepfert, Marnie L Elizaga, Alicia Sato, et al.
Plos Pathogens|February 25, 2011
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infectionGuido Ferrari, Bette Korber, Nilu Goonetilleke, et al.
Plos One|May 10, 2016
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre StudyCatherine A Cosgrove, Charles J Lacey, Alethea V Cope, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Plos One|December 6, 2011
Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41S Moses Dennison, Laura L Sutherland, Frederick H Jaeger, et al.
Communications Biology|October 2, 2018
IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cellsMaria Blasi, Donatella Negri, Celia LaBranche, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2006
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trialNina D Russell, Barney S Graham, Michael C Keefer, et al.
The Journal of Clinical Investigation|February 19, 2019
Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody responseYongjun Sui, George K Lewis, Yichuan Wang, et al.
JCI Insight|June 24, 2024
Innate protection against intrarectal SIV acquisition by a live SHIV vaccineYongjun Sui, Thomas J Meyer, Christine M Fennessey, et al.
Frontiers in Immunology|January 24, 2022
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1sWilliam D Tolbert, Dung N Nguyen, Marina Tuyishime, et al.
Pageof 53